These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 1714707
1. [Phase II study of YM881 (zinostatin stimalamer) suspension injected into the hepatic artery. Research Group for Intra-arterial Injection Therapy with YM881]. Taguchi T, Saito T, Ota J, Nakao I, Ohashi K, Nakamura H, Konno T. Gan To Kagaku Ryoho; 1991 Aug; 18(10):1665-75. PubMed ID: 1714707 [Abstract] [Full Text] [Related]
2. [Phase I study of YM881 (zinostatin stimalamer) suspension by hepatic arterial infusion. Research Group for Intra-arterial Infusion Therapy with YM881]. Taguchi T, Saito T, Ota J, Nakao I, Ohashi K, Nakamura H, Konno T. Gan To Kagaku Ryoho; 1991 Aug; 18(10):1657-63. PubMed ID: 1651686 [Abstract] [Full Text] [Related]
3. [Early phase II study of YM 881 (zinostatin stimalamer) by intravenous injection. Research group for intravenous YM 881]. Saito T, Nakao I, Wakui A, Niitani H, Kurihara M, Konno T, Tsukagoshi S, Maeda H. Gan To Kagaku Ryoho; 1991 Jul; 18(8):1319-23. PubMed ID: 1829883 [Abstract] [Full Text] [Related]
4. [Study on the intra-tumor tissue concentration of zinostatin stimalamer in the liver following intra-arterial injection of zinostatin stimalamer (YM881) suspension]. Toge T, Jinushi K, Sawamura A, Matsuki K. Gan To Kagaku Ryoho; 1991 Aug; 18(10):1677-80. PubMed ID: 1651687 [Abstract] [Full Text] [Related]
5. [Phase I clinical study of zinostatin stimalamer (YM 881) by intravenous injection]. Saito T, Nakao I, Wakui A, Kurihara M, Niitani H, Konno T, Tsukagoshi S, Maeda H. Gan To Kagaku Ryoho; 1991 Jul; 18(8):1311-8. PubMed ID: 1829882 [Abstract] [Full Text] [Related]
6. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma]. Yoshikawa M, Ebara M, Fukuda H, Sugiura N, Saisho H. Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684 [Abstract] [Full Text] [Related]
7. [Intra-arterial infusion of SMANCS for treatment of patients with hepatocellular carcinoma--adverse reactions and complications]. Sakaguchi T, Yoshimatsu S, Sagara K, Yamashita Y, Takahashi M. Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():64-9. PubMed ID: 9512690 [Abstract] [Full Text] [Related]
10. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol]. Konno T, Tabaru K, Isogai M, Nagamitsu A, Oda T. Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681 [Abstract] [Full Text] [Related]
11. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma]. Takizawa K, Honda M, Obuchi M, Matsuoka S, Shima H, Uchiyama K, Hasebe S, Doai K, Satoh S, Kuniyasu Y. Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683 [Abstract] [Full Text] [Related]
12. [Arterial infusion chemotherapy with SMANCS]. Nekohashi T, Maruno J, Sanjou A, Toda G. Nihon Rinsho; 2001 Oct; 59 Suppl 6():629-33. PubMed ID: 11762025 [No Abstract] [Full Text] [Related]
13. [Evaluation of hepatic artery occlusion after intra-arterial infusion of SMANCS in patients with hepatocellular carcinoma]. Sakaguchi T, Yoshimatsu S, Sagara K, Yamashita Y, Takahashi M. Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Oct; 58(12):700-4. PubMed ID: 9844406 [Abstract] [Full Text] [Related]
14. [Principle and therapeutic effect of lipophilic anticancer agent [SMANCS/lipiodol]: selective targeting with oily contrast medium]. Maeda H. Gan To Kagaku Ryoho; 1989 Oct; 16(10):3323-31. PubMed ID: 2552930 [Abstract] [Full Text] [Related]
16. Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial. Okusaka T, Kasugai H, Shioyama Y, Tanaka K, Kudo M, Saisho H, Osaki Y, Sata M, Fujiyama S, Kumada T, Sato K, Yamamoto S, Hinotsu S, Sato T. J Hepatol; 2009 Dec; 51(6):1030-6. PubMed ID: 19864035 [Abstract] [Full Text] [Related]